ClearPoint Neuro Inc. logo

ClearPoint Neuro Inc.

CLPT | NASDAQ
Chart Builder DCF Calculator
$13.97
+$0.14 (+1.01%)
At close: Sep 21, 2026, 4:00 PM ET
$14
+$0.03 (+0.21%)
Pre-market: Sep 22, 2026, 7:50 AM ET

Market Data

Market Cap
$418.95M
Enterprise Value
$453.54M
Beta
1.27
Average Volume
689.83K
Shares Outstanding (Diluted)
29.86M
Shares Change YoY
5.66%
Institutional Ownership
43.98%
Exchange
NASDAQ
ISIN
US18507C1036

Price Performance

Price Change 1M
-9.5%
Price Change 3M
-24.6%
Price Change 6M
47.2%
Price Change YTD
-0.4%
Price Change 1Y
16.1%
Price Change 3Y
171.8%
Price Change 5Y
-24.7%
1M CAGR (ann.)
-1.7%
1Y CAGR (ann.)
23.1%
5Y CAGR (ann.)
-5.3%
All-Time CAGR
-5.2%

Valuation

PE Ratio
-11.84
Forward PE
N/A
PEG Ratio
0.34
Forward PEG
1.40
PS Ratio
9.91
Forward PS
7.40
PB Ratio
38.88
P/FCF Ratio
-13.39
P/Adj. FCF Ratio
-10.53
P/OCF Ratio
-13.83
EV/Sales
10.73
EV/EBIT
-14.71
EV/EBITDA
-16.54
EV/FCF
-14.49
Earnings Yield
-8.4%
FCF Yield
-7.5%
Adj. FCF Yield
-9.5%

Financial Health

Net Debt
$21.06M
Total Debt
$63.95M
Cash & Short-Term Investments
$29.36M
Total Assets
$86.74M
Current Ratio
4.73
Quick Ratio
3.87
Debt / Equity Ratio
5.93
Debt / EBITDA
-2.33
Debt / FCF
-2.04
OCF / Debt
-0.47
Interest Coverage
-7.68
Altman Z-Score
-0.68
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
62.6%
Operating Profit Margin
-73.4%
EBITDA Margin
-64.9%
Net Profit Margin
-81.8%
FCF Margin
-74.0%
Adj. FCF Margin
-94.1%
SBC / Revenue
20.1%
SBC Impact (per share)
-27.1%

Returns

Return on Assets
-39.9%
Return on Equity
-188.1%
Return on Invested Capital
-40.5%
Return on Capital Employed
-40.6%
Return on Tangible Assets
-52.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
24.9%
Revenue CAGR 5Y
23.6%
Revenue CAGR 10Y
23.2%
EPS CAGR 3Y
-26.1%
EPS CAGR 5Y
-10.7%
EPS CAGR 10Y
3.8%
FCF CAGR 3Y
-60.7%
FCF CAGR 5Y
-13.1%
FCF CAGR 10Y
-18.1%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
3
EPS Growth Next 3Y
10.2%
Revenue Growth Next 3Y
22.6%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$0.27
EPS Growth Est (next Q)
28.6%
Revenue Est (next Q)
$12.3M
Revenue Growth Est (next Q)
38.8%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$23.50
Price Target Upside
68.2%

Cash Flow

Operating Cash Flow
$-30.18M
Free Cash Flow
$-31.29M
Adj. Free Cash Flow
$-39.78M
FCF Per Share
-$1.05
OCF Per Share
-$1.01
OCF/S Ratio
-71.4%

Income Statement

Revenue
$42.28M
Gross Profit
$26.47M
Operating Income
$-31.04M
EBITDA
$-27.42M
Net Income
$-34.57M
EPS (Diluted)
-$1.18
Revenue / Employee
$245.81K
Profit / Employee
$-200.97K
Employees
172

© 2026 bestshares.com. All rights reserved.